Total Payments
$19,541
2024 Payments
$1,384
Companies
49
Transactions
1,083
Medicare Patients
3,335
Medicare Billing
$384,662
Payment Breakdown by Category
Food & Beverage$19,063 (97.6%)
Education$477.75 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,063 | 1,055 | 97.6% |
| Education | $477.75 | 28 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,357 | 173 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,997 | 221 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,192 | 59 | $0 (2024) |
| GENZYME CORPORATION | $980.36 | 43 | $0 (2024) |
| Mylan Specialty L.P. | $910.63 | 58 | $0 (2024) |
| United Therapeutics Corporation | $848.80 | 54 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $762.81 | 67 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $713.48 | 35 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $693.94 | 30 | $0 (2024) |
| Insmed, Inc. | $663.74 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,384 | 59 | AstraZeneca Pharmaceuticals LP ($311.99) |
| 2023 | $2,740 | 124 | AstraZeneca Pharmaceuticals LP ($438.83) |
| 2022 | $2,647 | 139 | AstraZeneca Pharmaceuticals LP ($692.88) |
| 2021 | $3,091 | 154 | AstraZeneca Pharmaceuticals LP ($604.70) |
| 2020 | $1,705 | 102 | AstraZeneca Pharmaceuticals LP ($432.39) |
| 2019 | $1,898 | 141 | GlaxoSmithKline, LLC. ($391.03) |
| 2018 | $3,437 | 199 | GlaxoSmithKline, LLC. ($633.58) |
| 2017 | $2,638 | 165 | GlaxoSmithKline, LLC. ($464.16) |
All Payment Transactions
1,083 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $115.92 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Cardio-renal | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Respiratory | ||||||
| 08/22/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Pulmonology | ||||||
| 08/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: Immunology | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Respiratory | ||||||
| 07/24/2024 | United Therapeutics Corporation | ORENITRAM (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 07/16/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Pulmonology | ||||||
| 07/15/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.32 | General |
| Category: IMMUNOLOGY | ||||||
| 07/03/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Respiratory | ||||||
| 06/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.44 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: IMMUNOLOGY | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Respiratory | ||||||
| 06/07/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Immunology | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: Respiratory | ||||||
| 05/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/22/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Respiratory | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Respiratory | ||||||
| 05/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: RESPIRATORY | ||||||
| 05/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $28.76 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 726 | 1,022 | $182,080 | $85,078 |
| 2022 | 9 | 884 | 1,281 | $223,034 | $104,641 |
| 2021 | 8 | 1,003 | 1,397 | $255,752 | $118,384 |
| 2020 | 8 | 722 | 1,123 | $199,637 | $76,559 |
Total Patients
3,335
Total Services
4,823
Medicare Billing
$384,662
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 325 | 606 | $107,262 | $58,975 | 55.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 79 | 79 | $29,072 | $13,234 | 45.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 55 | 64 | $16,640 | $8,678 | 52.1% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 51 | 51 | $6,885 | $1,535 | 22.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 23 | 26 | $1,300 | $696.02 | 53.5% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 77 | 78 | $8,932 | $678.24 | 7.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 23 | 24 | $2,880 | $584.73 | 20.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 77 | 78 | $8,932 | $581.04 | 6.5% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 16 | 16 | $177.12 | $116.80 | 65.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 356 | 729 | $129,033 | $71,078 | 55.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 98 | 98 | $36,064 | $16,834 | 46.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 63 | 78 | $20,280 | $10,529 | 51.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 21 | $2,415 | $1,523 | 63.1% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 44 | 46 | $6,210 | $1,372 | 22.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 125 | 126 | $12,882 | $1,067 | 8.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 125 | 127 | $12,984 | $924.98 | 7.1% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 26 | 29 | $1,450 | $779.15 | 53.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 13 | 13 | $1,560 | $411.21 | 26.4% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2022 | 14 | 14 | $154.98 | $122.42 | 79.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 303 | 634 | $112,218 | $61,274 | 54.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 167 | 167 | $61,456 | $28,157 | 45.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 109 | 156 | $40,560 | $21,409 | 52.8% |
| 94375 | Respiratory diagnostic testing (flow volume loop) | Office | 2021 | 80 | 87 | $11,745 | $2,632 | 22.4% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 37 | 38 | $4,560 | $1,414 | 31.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2021 | 41 | 47 | $2,350 | $1,271 | 54.1% |
About Dr. Thomas Tan, MD
Dr. Thomas Tan, MD is a Pulmonary Disease healthcare provider based in Kennewick, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285708347.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Tan, MD has received a total of $19,541 in payments from pharmaceutical and medical device companies, with $1,384 received in 2024. These payments were reported across 1,083 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($19,063).
As a Medicare-enrolled provider, Tan has provided services to 3,335 Medicare beneficiaries, totaling 4,823 services with total Medicare billing of $384,662. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine, Sleep Medicine
- Location Kennewick, WA
- Active Since 11/20/2006
- Last Updated 08/09/2013
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1285708347
Products in Payments
- DUPIXENT (Biological) $1,686
- TRELEGY ELLIPTA (Drug) $1,240
- NUCALA (Biological) $897.13
- SYMBICORT (Drug) $765.92
- Arikayce (Drug) $630.05
- TEZSPIRE (Biological) $559.86
- FASENRA (Biological) $478.57
- BREZTRI (Drug) $472.02
- AirDuo Digihaler (Drug) $467.53
- XOLAIR (Biological) $463.92
- ORENITRAM (Drug) $447.53
- Kerendia (Drug) $431.15
- Ozempic (Drug) $425.70
- UTIBRON (Drug) $411.75
- ANORO (Drug) $393.17
- Prolastin-C Liquid (Biological) $392.65
- SMARTVEST (Device) $366.18
- TYVASO (Drug) $344.92
- Yupelri (Drug) $342.82
- JARDIANCE (Drug) $329.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.